Turnover
≈ €100,000 estimated
The micro format states no turnover.
MEDCYPATH
Lifetime
1 annual account with figurespeak €25,056 (2025)
€25,056
peak €19,442 (2025)
€19,442
peak €24,442 (2025)
€24,442
€7,068
Board1 name since 2025
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Incorporation 03-101 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsStarting capital
€5,000 100 shares
Checked score
57
Fair
Financially stronger than 74% of micro companies without a NACE code
Probability in this band: 1.5% to 4.2%
Bankruptcy probability within 12 months
1.7% Moderate
0%0.5%1.5%4%10%≥ 25%
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Financial strengthStrong
Score breakdown
raises risk
Founded in 2025
No main activity registered
lowers risk
Figures for financial year 2025 (filed on 26-06-2026)
Equity €24,442 (77.6% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 51% on liquidity and 90% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the moderate class on 30-06-2025, 2.4% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 11,279 companies had the same profile as MEDCYPATH has now. Each dot stands for 29 companies, two years later.
96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
The bankruptcy probability of MEDCYPATH itself is higher: 1.7% within 12 months. It rests on far more data about MEDCYPATH than the profile alone.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 11,279 companies, not a prediction for MEDCYPATH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.39, above the usual 1.5. Short-term debt is 22.4% and cash 10.2% of total assets. 22.4% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
35 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Board and ownership
- VAN ESSCHE, Cyril Corentin Ann Louis Pierre 100 sharesdeed of 03-10-2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1028477142
Incorporation
Founding capital of €5,000, 100 shares · Founder: VAN ESSCHE, Cyril Corentin Ann Louis Pierre · Appointment: VAN ESSCHE, Cyril Corentin Ann Louis Pierre (director) · published on 03-10-2025 · Gazette deed
First establishment
Rue Marguerite 20, Grez-Doiceau
Official details
Source: KBO- Status
- Active since 01-10-2025Normal situation
- Activity
- “L'exercice, en son nom et pour son compte, de la médecine et plus particulièrement…” (deed in French)From the articlesNo NACE code in the KBO yet
- Establishment unit
- 2.380.746.8181390 Grez-Doiceau, since 01-10-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 28-05-2026
Annual accounts 2025
- €31,510
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on MEDCYPATH
The computed 12-month bankruptcy probability of MEDCYPATH is 1.7% (moderate). The 2025 annual accounts show equity of €24,442 and a net result of €19,442.
The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDCYPATH
- What is the company number of MEDCYPATH?
- The company number of MEDCYPATH is 1028.477.142. The VAT number is the same number with BE in front: BE 1028.477.142.
- Where is MEDCYPATH based?
- The registered office is at Rue Marguerite 20, 1390 Grez-Doiceau.Company details
- What is the legal form of MEDCYPATH?
- MEDCYPATH is a private limited company (BV).
- When was MEDCYPATH founded?
- MEDCYPATH was founded on 01-10-2025.
- Is MEDCYPATH still active?
- Yes, MEDCYPATH is an active enterprise in the KBO register.
- What is the turnover of MEDCYPATH?
- The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €25,056 and 2,936 comparable companies of the same size. It probably lies between €61,000 and €180,000. It is a rough estimate.Financials
- Is MEDCYPATH profitable?
- In financial year 2025, MEDCYPATH made a profit of €19,442.
- Where can I find the annual accounts of MEDCYPATH?
- MEDCYPATH filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.